Form 4: Pfizer CEO Albert Bourla Acquires Phantom Stock Units

Pfizer's CEO, Albert Bourla, acquired 20 phantom stock units through the company's Supplemental Savings Plan.

Summary

• Albert Bourla, the Chairman and CEO of Pfizer, acquired 20 phantom stock units on December 31, 2024.
• These units were acquired through the Pfizer Supplemental Savings Plan.
• Each unit represents one phantom share of common stock.
• The units are settled in cash following the reporting person's separation from service.
• The units can be transferred into an alternative investment account at any time.
• Following this transaction, Mr. Bourla beneficially owns 690,585 phantom stock units.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation, which is generally viewed neutrally to positively by investors. The acquisition of phantom stock units is a common practice and does not indicate any significant positive or negative sentiment.

Positives

• The acquisition of phantom stock units aligns the CEO's interests with the company's performance.
• The Supplemental Savings Plan provides a mechanism for long-term wealth accumulation for the CEO.

Industry Context

This is a routine filing related to executive compensation and is common practice for publicly traded companies.

Comparison to Industry Standards

• Many large pharmaceutical companies use phantom stock units as part of their executive compensation packages.
• These plans are designed to align executive interests with shareholder value.
• The specific terms of these plans vary from company to company, but the general structure is similar.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the CEO's interests with the company's performance.

Key Dates

Keywords

Pfizer, Albert Bourla, phantom stock units, Supplemental Savings Plan, executive compensation, SEC Form 4